Filing Details

Accession Number:
0001140361-17-008215
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-17 20:30:53
Reporting Period:
2017-02-15
Filing Date:
2017-02-17
Accepted Time:
2017-02-17 20:30:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1433714 Castlight Health Inc. CSLT Services-Computer Processing & Data Preparation (7374) 261989091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1601554 M. Giovanni Colella C/O Castlight Health, Inc.
150 Spear St., Suite 400
San Francisco CA 94105
Ceo And Co-Founder Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class B Common Stock Acquisiton 2017-02-15 9,187 $0.00 37,617 No 4 M Direct
Class B Common Stock Disposition 2017-02-16 3,751 $3.56 33,866 No 4 S Direct
Class B Common Stock Acquisiton 2017-02-16 76,250 $0.00 110,116 No 4 M Direct
Class B Common Stock Disposition 2017-02-17 31,210 $3.72 78,906 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class B Common Stock Restricted Stock Units Disposition 2017-02-15 9,187 $0.00 9,187 $0.00
Class B Common Stock Restricted Stock Units Disposition 2017-02-16 76,250 $0.00 76,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
82,688 No 4 M Direct
228,750 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class B Common Stock 5,426 Indirect By living trust
Footnotes
  1. Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on June 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 4.
  2. Represents the aggregate number of shares sold by the Reporting Person on the same day at different prices. All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $3.475 to $3.625 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  4. Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
  5. Represents the weighted average sales price per share. The shares sold at prices ranging from $3.55 to $3.825 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  6. Reporting Person serves as a co-trustee.
  7. Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
  8. The RSUs vest over 4 years as follows: 25% of the RSUs vested on May 15, 2016 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting.
  9. The RSUs vest over 4 years as follows: 25% of the RSUs vested on February 16, 2017 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.